Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin
The prediction of clinical drug-drug interactions (DDIs) due to mechanism-based inhibitors of CYP3A is complicated when the inhibitor itself is metabolized by CYP3A, as in the case of clarithromycin. Previous attempts to predict the effects of clarithromycin on CYP3A substrates, e.g., midazolam, fai...
Saved in:
Main Authors: | Quinney S.K., Zhang X., Lucksiri A., Gorski J.C., Li L., Hall S.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-76149083862&partnerID=40&md5=474c87e21322e9d8b54c62945acb791f http://cmuir.cmu.ac.th/handle/6653943832/4621 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin
by: Sara K. Quinney, et al.
Published: (2018) -
Clarithromycin
by: สุวัฒนา จุฬาวัฒนทล
Published: (2020) -
Quantitative Prediction of CYP3A4- and CYP3A5-Mediated Drug Interactions
by: Yingying Guo, et al.
Published: (2020) -
Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction
by: Yeo, K.P., et al.
Published: (2014) -
Prediction of Maternal and Fetal Pharmacokinetics of Dolutegravir and Raltegravir Using Physiologically Based Pharmacokinetic Modeling
by: Xiaomei I. Liu, et al.
Published: (2020)